Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease.

MLA

Fernandez, Mercedes, et al. “Thyroid Hormone Administration Enhances Remyelination in Chronic Demyelinating Inflammatory Disease.” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 46, Nov. 2004, pp. 16363–68. EBSCOhost, https://doi.org/10.1073/pnas.0407262101.

APA

Fernandez, M., Giuliani, A., Pirondi, S., D’Intino, G., Giardino, L., Aloe, L., Levi-Montalcini, R., & Calzà, L. (2004). Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proceedings of the National Academy of Sciences of the United States of America, 101(46), 16363–16368. https://doi.org/10.1073/pnas.0407262101

Chicago

Fernandez, Mercedes, Alessandro Giuliani, Stefania Pirondi, Giulia D’Intino, Luciana Giardino, Luigi Aloe, Rita Levi-Montalcini, and Laura Calzà. 2004. “Thyroid Hormone Administration Enhances Remyelination in Chronic Demyelinating Inflammatory Disease.” Proceedings of the National Academy of Sciences of the United States of America 101 (46): 16363–68. doi:10.1073/pnas.0407262101.